🇺🇸 Ebixa in United States

577 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fall — 116 reports (20.1%)
  2. Confusional State — 82 reports (14.21%)
  3. Drug Interaction — 67 reports (11.61%)
  4. Somnolence — 60 reports (10.4%)
  5. Malaise — 55 reports (9.53%)
  6. Asthenia — 40 reports (6.93%)
  7. Condition Aggravated — 40 reports (6.93%)
  8. Vomiting — 40 reports (6.93%)
  9. Pyrexia — 39 reports (6.76%)
  10. General Physical Health Deterioration — 38 reports (6.59%)

Source database →

Ebixa in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United States

Frequently asked questions

Is Ebixa approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ebixa in United States?

Konkuk University Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.